Addressing Disparities in Cancer Care for Latino Medicare Beneficiaries
NCT ID: NCT00385866
Last Updated: 2016-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1272 participants
INTERVENTIONAL
2006-10-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Kin KeeperSM: Reducing Disparities Through Cancer Literacy and Screening
NCT01910350
A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
NCT06350500
Increasing African Immigrant Women's Participation in Breast Cancer Screening
NCT04450264
Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer
NCT03075540
Breast Health Education for Underserved Latino Women
NCT02205736
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The overall aim of this project is to institute an innovative cancer care facilitation program for elderly Latinos in the city of Newark, NJ. The goal is to reduce the disparities observed in screening, time to diagnosis and treatment services, by utilizing a multidisciplinary team approach to health care, incorporating systems thinking methodology. Using the Multilevel Approach to Community Health (MATCH) planning model , the program will incorporate community outreach, education, and access to screening, and patient assistance in all aspects of the health care continuum. It will also include cultural and linguistic competency training for all those involved in the facilitation process. To accomplish this goal, we propose four objectives:
1. To establish a multidisciplinary team that will utilize a systems thinking approach to design and structure the delivery of cancer screening, diagnosis and treatment facilitation services.
2. To build a collaborative consortium between program partners to improve screening outcomes, that will encourage the utilization of services in the community.
3. To improve the delivery of cancer prevention and treatment facilitation by providing cultural and linguistic competency training to the multidisciplinary team, providers, and the community.
4. To demonstrate the effectiveness of the intervention in reducing the burden of cancer, by increasing screening rates, improving time to diagnosis and delivery of treatment services, patient satisfaction, and appropriate use of Medicare services.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Comparison Group
The control or lesser intervention group, will receive cancer screening information on a quarterly basis, with no facilitation of services.
cancer screening and health education
The control group will receive cancer screening and health education materials on a quarterly basis but will not have access to patient navigation services.
Intervention group
The intervention group are those participants who were randomly assigned to receive facilitation of services in the form of patient navigation for the duration of the study.
cancer screening and health education
The control group will receive cancer screening and health education materials on a quarterly basis but will not have access to patient navigation services.
facilitation of Services to improve cancer screening
The intervention group will receive cancer education and faciliation of services in the form of patient navigation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cancer screening and health education
The control group will receive cancer screening and health education materials on a quarterly basis but will not have access to patient navigation services.
facilitation of Services to improve cancer screening
The intervention group will receive cancer education and faciliation of services in the form of patient navigation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Be of Hispanic/Latino Origin
2. Fluent in English and/or Spanish
3. Recipient of, Medicare Part A \& B, or combined Medicare/Medicaid
4. Not having a previous diagnosis of cancer
5. Be capable of giving written informed consent prior to any study related procedures.
6. Be available and willing to complete all study assessments as specified.
Cancer-Positive Group
1. Be of Hispanic/Latino Origin
2. Fluent in English and/or Spanish
3. Recipient of, Medicare Part A \& B, or combined Medicare/Medicaid
4. Having a previous diagnosis of cancer of the breast, cervix, colon and/or rectum, prostate, or lung.
5. Be capable of giving written informed consent prior to any study related procedures.
6. Be available and willing to complete all study assessments as specified.
Exclusion Criteria
2. Medicaid only beneficiaries
3. Institutionalized
4. Unable to provide written informed consent
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centers for Medicare and Medicaid Services
FED
University of Medicine and Dentistry of New Jersey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ana Natale-Pereira, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Rutgers, The State University of New Jersey
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UMDNJ
Newark, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0120060236
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.